Sofosbuvir and Daclatasvir
Medicine OverView
Sofosbuvir and Daclatasvir Tablets is an antiviral combination medicine used in the treatment of chronic Hepatitis C virus (HCV) infection. This combination contains Sofosbuvir, an NS5B polymerase inhibitor, and Daclatasvir, an NS5A inhibitor that work together to stop Hepatitis C virus replication.
Sofosbuvir and Daclatasvir Tablets helps reduce viral load, improve liver health, and support long-term management of chronic Hepatitis C infection. This combination is widely used in direct-acting antiviral (DAA) therapy protocols for different HCV genotypes.
Doctors may prescribe this medicine for chronic Hepatitis C patients with or without liver cirrhosis depending on viral genotype, liver condition, and treatment history.
This medicine should only be used under the supervision of qualified healthcare professionals experienced in antiviral treatment.
Sofosbuvir and Daclatasvir Tablets is used for the treatment and management of chronic Hepatitis C infection.
Doctors prescribe Sofosbuvir and Daclatasvir Tablets depending on viral genotype, liver function, treatment history, and patient response.
Sofosbuvir and Daclatasvir Tablets contains two antiviral medicines:
This combination works by:
By targeting multiple stages of viral replication, Sofosbuvir and Daclatasvir Tablets helps improve antiviral treatment effectiveness and supports long-term viral suppression.
Sofosbuvir and Daclatasvir Tablets offers several important benefits in Hepatitis C treatment.
Proper antiviral treatment and regular medical monitoring are important for improving long-term liver health and treatment success.
Chronic Hepatitis C is a viral infection that affects the liver and may lead to liver inflammation, fibrosis, cirrhosis, or liver complications if untreated.
Common symptoms may include:
Early diagnosis and specialist antiviral treatment help improve long-term liver health and viral control.
The dosage of Sofosbuvir and Daclatasvir Tablets depends on:
Important usage instructions:
Regular viral load monitoring and liver function tests may be required during treatment.
Like all medicines, Sofosbuvir and Daclatasvir Tablets may cause side effects in some patients.
Seek immediate medical attention if you experience:
Regular medical monitoring helps support safe and effective antiviral treatment.
Before using Sofosbuvir and Daclatasvir Tablets, inform your doctor if you have:
Important Warning: Hepatitis B reactivation may occur in some patients during antiviral treatment.
Do not stop treatment without medical advice.
Sofosbuvir and Daclatasvir Tablets may interact with several medicines.
Always inform your healthcare provider about all medicines, supplements, and herbal products you are using.
Pregnancy: Use during pregnancy should only occur if clearly advised by your healthcare provider.
Breastfeeding: Medical advice is recommended before use while breastfeeding.
Discuss potential risks and benefits with your healthcare provider before starting treatment.
Sofosbuvir and Daclatasvir Tablets is used for chronic Hepatitis C virus (HCV) infection treatment.
It contains Sofosbuvir and Daclatasvir antiviral medicines.
It works by blocking Hepatitis C virus replication and reducing viral multiplication.
Yes, reducing viral load may help support long-term liver health and reduce disease progression.
Completing the prescribed antiviral course helps improve treatment effectiveness and long-term viral suppression.
Yes, Sofosbuvir and Daclatasvir Tablets should only be used under specialist medical supervision.
You can buy Sofosbuvir and Daclatasvir Tablets online from a licensed pharmacy with a valid prescription. Always purchase antiviral medicines from trusted suppliers to ensure product authenticity, quality, and proper storage conditions.
Before purchasing online:
What do you think about this product?